Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thyroid Neoplasms 1 Sarcoma 1 Neoplasm Metastasis 1 Mesothelioma, Malignant 1 Endometrial Adenocarcinoma 1 Carcinoma, Medullary 1

Interventions

Ifosfamide 19 Doxorubicin 19 Filgrastim 17 Radiotherapy 13 Vincristine 11 Cyclophosphamide 11 Etoposide 9 Cisplatin 9 Granulocyte Colony-Stimulating Factor 8 Gene Expression Profiling 8 Trabectedin 7 Polymerase Chain Reaction 7 Dactinomycin 6 sargramostim 5 etoposide phosphate 5 Paclitaxel 5 Mesna 5 Chemotherapy, Adjuvant 4 Brachytherapy 4 pegfilgrastim 3 Topotecan 3 Microarray Analysis 3 Irinotecan 3 Immunohistochemistry 3 Imatinib Mesylate 3 Gemcitabine 3 Dexrazoxane 3 Base Sequence 3 olaparib 2 brostallicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Sarcoma × nintedanib × Clear all

NCT02808247 2021-09-20

ANITA

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡